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Despite only 4 years of publications, the Journal of Thoracic Oncology (JTO) has madea rapid ascent. In 2009, JTO received its first full impact factor (2008 impact factor)
of 3.5, which ranked it number 50 among 150 oncology journals. This impact factor was
based on publications in 2006 and 2007, our first 2 years of publication. In 2007 and 2008,
the International Association for the Study of Lung Cancer (IASLC) staging committee
published a number of landmark articles, including the new tumor, node, metastasis
staging system for non-small cell lung cancer, small cell lung cancer, and bronchial
carcinoid tumors.1–3 These articles are frequently sited, and so we optimistically await the
2009 impact factor due this spring or summer.
The number of manuscripts submitted has risen markedly. Manuscript submissions
doubled from 300 to 600 in 2006 to 2008. JTO finished 2009 with 750 submitted
manuscripts. Along with the increase in numbers, there has been a marked improvement
in the quality of the submissions and a proportional drop in the acceptance rate. All this
is good news for you, the readers of JTO. The journal is truly international with
manuscript submissions from Europe (Western and Eastern) totaling 25%, Asia/Australia
contributing 33%, and 25% from North American authors. Manuscripts submitted from
South America, Middle East, and Africa account for about 1% each and none from Russia.
I encourage more submissions from these areas of the world.
The JTO home page (www.JTO.org) was improved this year and is significantly more
user-friendly. The journal has not maximized the use of all the new features, such as lists or
grouping of similar articles, but work will be done on that throughout 2010. Other features for
subscribers include eTOCs that will deliver the current Table of Contents to your inbox. Our
accepted papers are also published ahead of print and can be found on the web site before the
print publication. Please let me know if any major problems arise in your use of the JTO web
site. If you have ideas for improvements in the web site, I would like to hear them. I admit that
I am not the most computer savvy individual and welcome your insights. A nice feature of the
JTO web site is to the ability to track the number of hits per article; the most frequently viewed
articles are the IASLC staging committee articles.
More foreign language editions of JTO are being published. The Japanese edition
continues to be published on a quarterly basis. The first Turkish edition of JTO was published
in 2009 with Dr. Atila Akkoc¸lu as editor in chief. Unfortunately, the Spanish edition of JTO
ceased publication due to funding constraints. Discussions are underway for a Chinese edition
of JTO, and I anticipate publication of the first issue in 2010.
Why is JTO doing well? Because of you, the members of IASLC, and our readers. Your
support has been tremendous both in terms of submission of excellent articles and your
unselfish contribution to the peer-review process. Please note the list of reviewers in this issue
of JTO. Reviewers are the backbone of peer-review process, and I am thankful to them. Also,
key to the journal’s success is our outstanding group of Associate Editors. They are major
contributors to the field of thoracic oncology. They do an outstanding job and are responsible
for the selection of excellent reviewers around the world. Thanks to their efforts, the JTO
average time to first decision for all submitted manuscripts is 24 days.
Although JTO is enjoying success after 4 short years, there is certainly ample room
for growth and improvement. The JTO is committed to provide rapid turnaround for
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author submissions and strives to improve the quality of the
publication. The goal is to provide you, the reader, with the
most pressing and current information in the field of thoracic
oncology. If you have ideas on how the JTO can do this
better, then please let me hear from you.
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